EdgarLookup

ABVC BIOPHARMA, INC. — All Filings

778 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A AW CERT CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
NT 10-K NOTIFICATION OF LATE FILING 0001213900-25-026367 Mar 31, 2025 Dec 31, 2024
8-K CURRENT REPORT 0001213900-25-021713 Mar 7, 2025 Mar 5, 2025
SCHEDULE 13G/A 0000929638-25-000810 Feb 14, 2025
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-25-002769 Jan 13, 2025 Jul 12, 2024
8-K CURRENT REPORT 0001213900-25-001211 Jan 6, 2025
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-099062 Nov 15, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-099059 Nov 15, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-099061 Nov 15, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-099058 Nov 15, 2024
10-Q QUARTERLY REPORT 0001213900-24-097840 Nov 14, 2024 Sep 30, 2024
8-K CURRENT REPORT 0001213900-24-097894 Nov 14, 2024
SC 13G/A 0000929638-24-003938 Nov 14, 2024
8-K CURRENT REPORT 0001213900-24-094178 Nov 4, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-090651 Oct 25, 2024
8-K CURRENT REPORT 0001213900-24-089013 Oct 18, 2024
8-K CURRENT REPORT 0001213900-24-077361 Sep 10, 2024
8-K CURRENT REPORT 0001213900-24-071145 Aug 20, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-070277 Aug 16, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-070271 Aug 16, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-070270 Aug 16, 2024
8-K CURRENT REPORT 0001213900-24-069338 Aug 15, 2024
10-Q QUARTERLY REPORT 0001213900-24-068907 Aug 14, 2024 Jun 30, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-066168 Aug 7, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-065797 Aug 7, 2024
EFFECT 9999999995-24-002346 Aug 1, 2024
POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 0001013762-24-001634 Jul 26, 2024
8-K CURRENT REPORT 0001213900-24-063627 Jul 23, 2024
424B4 PROSPECTUS 0001213900-24-061016 Jul 12, 2024
8-K CURRENT REPORT 0001213900-24-061028 Jul 12, 2024
EFFECT 9999999995-24-002046 Jul 1, 2024
CORRESP 0001213900-24-056630 Jun 27, 2024
UPLOAD 0000000000-24-007242 Jun 26, 2024
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-24-055809 Jun 25, 2024 Nov 16, 2023
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-24-055288 Jun 24, 2024 Mar 26, 2024
S-1 REGISTRATION STATEMENT 0001213900-24-054857 Jun 21, 2024
D 0001213900-24-047099 May 28, 2024
8-K CURRENT REPORT 0001213900-24-046419 May 24, 2024
8-K CURRENT REPORT 0001213900-24-046313 May 23, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-046294 May 23, 2024
424B4 PROSPECTUS SUPPLEMENT 0001213900-24-045843 May 22, 2024
424B4 PROSPECTUS 0001213900-24-045957 May 22, 2024
10-Q QUARTERLY REPORT 0001213900-24-044731 May 17, 2024 Mar 31, 2024
8-K/A FORM 8-K/A 0001213900-24-044798 May 17, 2024 Feb 8, 2024
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-24-043739 May 15, 2024 Mar 31, 2024
8-K CURRENT REPORT 0001213900-24-043229 May 15, 2024
8-K CURRENT REPORT 0001213900-24-041053 May 9, 2024
EFFECT 9999999995-24-001194 Apr 30, 2024
PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-24-036669 Apr 26, 2024
POS AM POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 0001213900-24-036125 Apr 25, 2024
8-K FORM 8-K 0001213900-24-034583 Apr 19, 2024